Standing Out in Excellence: Innovaderm’s Unmatched Commitment Through Client Stories
2024-01-07
Innovaderm is proud of its partnership with Nimbus Therapeutics for an investigational oral TYK2 inhibitor, in a Phase 2b trial for patients with moderate-to-severe psoriasis.
Innovaderm’s reputed teams once again proved their expertise throughout the whole project, from the study design all the way to the trial reports, under tight timelines.
“There are many CRO partners out there, but Innovaderm stands out among them as a dedicated, committed partner to their sponsors.” Gabrielle Poirier, Nimbus Therapeutics.
Let our satisfied clients detail our proficiency in managing dermatology clinical trials:
- Gabrielle Poirier, Vice President of Operations at Nimbus Therapeutics
- Bhaskar Srivastava, Senior Vice President of Clinical Development at Nimbus Therapeutics (now with Triveni Bio)
Newsletter
Join our science community with Press Forward, our quarterly newsletter. Get the latest in dermatology clinical research. Subscribe now!
